Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Safety and Tolerability Evaluation of Ascending Single Oral Doses of Metacavir Enteric-coated Capsules Using a Randomized，Double-blind, Placebo-controlled Design Conducted in Chinese Healthy Adult Volunteers

NCT03173599 is registered in ClinicalTrials.gov with Guangzhou Yipinhong Pharmaceutical CO.,LTD as lead sponsor.

NCT NCT03173599
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03173599 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Safety and Tolerability Evaluation of Ascending Single Oral Doses of Metacavir Enteric-coated Capsules Using a Randomized，Double-blind, Placebo-controlled Design Conducted in Chinese Healthy Adult Volunteers
Lead sponsor
Guangzhou Yipinhong Pharmaceutical CO.,LTD
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2010
Completion date
April 30, 2011
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b